C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom

Patents for C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom (40,304)
12/2004
12/15/2004	EP0988263B1 Process for the production of radioiodinated neuroreceptor agents
12/15/2004	CN1555355A Substituted 4-aminocyclohexanol derivatives
12/15/2004	CN1554768A Preparation of lactams from aliphatic alpha,omega dinitriles
12/15/2004	CN1554746A Preparation of lactams from aliphatic alpha,omega dinitriles
12/15/2004	CN1554646A Preparation of lactams from aliphatic alpha,omega dinitriles
12/15/2004	CN1179944C 2-oxo-1-pyrrolidine derivatives, process for preparing them and their uses
12/14/2004	US6831199 Pyrimidine compounds and derivatives thereof
12/14/2004	US6831106 Vitamin D analogues
12/14/2004	US6831096 Effective against both A and B forms of influenza; oral bioavailability
12/14/2004	US6831094 For therapy of central nervous system disorders such as anxiety, depression, motor disorders
12/14/2004	CA2235146C Herbicidal sulfonamides
12/14/2004	CA2180867C Monomeric diols and phosphate linked oligomers formed therefrom
12/14/2004	CA2154170C Cyclic imide thione activated polyalkylene oxides
12/10/2004	WO2004108677A1 Antithrombotic ethers
12/09/2004	WO2004106411A2 Biodegradable poly(beta-amino esters) and uses thereof
12/09/2004	WO2004106301A1 Process for the synthesis of distamycin and derivatives thereof using 1-methyl-4-formylamino-2-pyrrolecarbonyl chloride iteratively as an intermediate
12/09/2004	WO2004106300A1 Captopril derivatives
12/09/2004	WO2004106299A2 Substituted pyrrole derivatives and their use as hmg-co inhibitors
12/09/2004	WO2004106295A2 Substituted piperodines and pyrrolidines as calcium sensing receptor modulators and method
12/09/2004	WO2004106289A1 Protease inhibitors
12/09/2004	WO2004105754A1 Nitrooxyderivatives of fluvastatin, pravastatin, cerivastatin, atorvastatin and rosuvastatin as cholesterol-reducing agents with improved anti-inflammatory, antithrombotic and antiplatelet activity
12/09/2004	WO2004105750A1 3-aminomethyl-pyrrolidines as n-type calcium channel blockers
12/09/2004	WO2004096761A8 Aromatic oxyphenyl and aromatic sulfanylphenyl derivatives
12/09/2004	WO2004089892A3 Diarylmethyl and related compounds having beta2 andrenergic receptor agonist and muscarinic receptor antagonist activity
12/09/2004	US20040249185 Process for the arylation of aza-heterocycles with activated aromatics in presence of caesium carbonate
12/09/2004	US20040249169 Converting 1-benzyl-3-aminopyrrolidine into an equimolar salt with an optically inactive acid; and recovering the salt as crystals
12/09/2004	US20040248981 Excellent inhibitory activity against factor Xa; anticoagulants; blood coagulation disorder, thrombotic disease, cerebral infarction, myocardial infarction, or peripheral circulation disorder
12/09/2004	US20040248967 Promoter for production of nitric oxide or nitric oxide synthase, and cosmetic or pharmaceutical composition comprising the same
12/09/2004	US20040248961 Oxidation base compound has the nitrogen-based quaternary onium group; oxidation dye precursors; hair coloring with oxidizer; multi-compartment kit; chromatic, fast coloration
12/09/2004	US20040248938 Substituted piperidines
12/09/2004	US20040248936 such as (R)-1-{4-[4-(4-Phenoxy-2-propyl-phenoxy)-butoxy]-benzenesulfonyl}-azetidine-2-carboxylic acid, used as peroxisome proliferator-activated receptor agonists; hypoglycemic agents
12/09/2004	US20040248931 Poly(ADP-ribose)polymerase inhibitors; cerebral infarction; such as 3-[2-(3-hydroxypyrrolidin-1-yl)ethyl]-5-methyl-2H-isoquinolin-1-one; synthesis
12/09/2004	US20040248872 Safe for agricultural or gardening use; effective against insects and mammals
12/09/2004	US20040248857 treatment of gram positive, gram negative and antibiotic resistant infections; 1,11-dioxo-2-naphthacenecarboxamide derivatives
12/09/2004	US20040248820 Administering 2-phthalimidoglutaric acid; vision defects; antitumor agents; anticancer agents
12/09/2004	US20040248740 for controlling undesirable plants
12/09/2004	CA2753318A1 Substituted pyrrole derivatives
12/09/2004	CA2527722A1 Biodegradable poly(beta-amino esters) and uses thereof
12/09/2004	CA2527382A1 Captopril derivatives
12/09/2004	CA2527168A1 Nitrooxyderivatives of fluvastatin, pravastatin, cerivastatin, atorvastatin and rosuvastatin as cholesterol-reducing agents with improved anti-inflammatory, antithrombotic and antiplatelet activity
12/09/2004	CA2527159A1 3-aminomethyl-pyrrolidines as n-type calcium channel blockers
12/09/2004	CA2526730A1 Substituted pyrrole derivatives
12/08/2004	EP1483578A2 Artificial receptors, building blocks, and methods
12/08/2004	EP1483242A1 Nitrosodiphenylamine derivatives and their pharmaceutical use against oxidative stress pathologies
12/08/2004	EP1483238A1 Method for the simultaneous production of tetrahydrofurans and pyrrolidones
12/08/2004	EP1483236A1 Aminoalcohol derivatives as beta-3 adrenergic receptor agonists
12/08/2004	EP1483228A1 Nk1 antagonists
12/08/2004	EP1482940A2 Prodrugs of substituted polycyclic compounds useful for selective inhibition of the coagulation cascade
12/08/2004	EP1482926A2 Amino-methyl substituted tetracycline compounds
12/08/2004	EP1482919A1 Pharmaceutical composition that is used to control blood glucose in patients with type 2 diabetes
12/08/2004	EP1119548B1 3-(3-chloro-4-hydroxyphenylamino)-4-(2-nitrophenyl)-1h-pyrrole-2,5-dione as glycogen synthase kinase-3 inhibitor (gsk-3)
12/08/2004	EP1114040B1 PROCESS FOR OBTAINING HMG-CoA REDUCTASE INHIBITORS OF HIGH PURITY
12/08/2004	CN1553897A Dolastatin 10 derivatives
12/08/2004	CN1553892A Novel compounds and compositions as cathepsin inhibitors
12/08/2004	CN1553797A Carboxylate-gated-nitroxide (CGN) compounds and compositions and methods of use thereof
12/08/2004	CN1553784A Magnetic resonance imaging method and device and RF receiving coil therefor
12/08/2004	CN1178992C Method for preparing deep colour perylene dye
12/08/2004	CN1178936C Sulfonyl-pyrrolidine derivatives
12/08/2004	CN1178935C 1,3-disubstituted pyrrolidines as alpha-2-adrenoceptor antagonists
12/08/2004	CN1178932C Amide derivatives
12/08/2004	CN1178927C Histamine H3 receptor ligands
12/08/2004	CN1178922C Substituted 1-aminoalkyl-lactams compound and their use as muscarinic receptor antagonists
12/08/2004	CN1178913C Aromatic heterocycle compounds having HIV integrase inhibiting activities
12/08/2004	CN1178912C Small molecule inhibitors of rotamase enzyme activity
12/08/2004	CN1178911C Pyrrolidine and piperidine derivatives and their use for treatment of neurodegenerative disorders
12/08/2004	CN1178906C N-hydroxyformamide derivatives as inhibitors of matrix metalloproteinases
12/08/2004	CN1178905C Novel peptide derivative
12/08/2004	CN1178901C New-cyclic alpha-amino-gamma hydroxy amide compound and its preparing method and medicinal composition containing said compound
12/07/2004	US6828442 Preparation of n-protected-3-pyrrolidine-lactam substituted phosphonium salts
12/07/2004	US6828427 Oligomeric aminodiol-containing compounds, libraries thereof, and process of preparing the same
12/07/2004	US6828278 Efficient, low cost; one step; catalytic
12/07/2004	US6828277 Production of N-aryl-2-lactam and N-alkyl-2-lactam by reductive amination of lactones with aryl and alkyl nitro compounds
12/07/2004	CA2070961C Thiol-reactive maleimido-based radiolabeling reagents
12/02/2004	WO2004103995A1 N-acyl nitrogen heterocycles as ligands of peroxisome proliferator-activated receptors
12/02/2004	WO2004103993A1 Dipeptidyl peptidase inhibitors
12/02/2004	WO2004103968A1 Sulfopyrroles
12/02/2004	WO2004103965A1 Process for rectifying n-vinyl-2-pyrrolidone
12/02/2004	WO2004103309A2 Immunosuppressant compounds and compositions
12/02/2004	WO2004076388A3 Process for preparing 2-methylpyrrolidine and specific enantiomers thereof
12/02/2004	US20040242928 Reverse hydroxamic acid derivatives
12/02/2004	US20040242916 Process for preparation of 7-amino syn 3,5-dihydroxy heptanoic acid derivatives, intermediates thereof and methods for their preparation
12/02/2004	US20040242900 Liquid phase reacting of gamma-butyrolactone with ammonia and water; heating, pressurization
12/02/2004	US20040242899 Anticholesterol agents; reacting atorvastatin with calcium acetate; salt formation; heating; filtration; distillation
12/02/2004	US20040242898 Antidiabetic agents; metabolism diosrders; hypotensive agents; cardiovascular disorders; reacting 2,2,3,3-tereafluorobutane with primary amine; cyclization
12/02/2004	US20040242889 Hydrogenation of (acylamino)acrylate using ruthenium complex hydrogenation catalyst
12/02/2004	US20040242888 Process for producing 1-alkoxycarbonyl nitrogenous saturated heterocyclic derivative
12/02/2004	US20040242868 Controlling cytokines; antiinflammatory agents; rheumatic disoreders; skin disorders; respiratory system disorders; Alzheimer's disease; Parkinson's disease; Huntington"s disease ; amyotrophic lateral sclerosis
12/02/2004	US20040242672 Pyrrolidine derivatives
12/02/2004	US20040242671 Use of 2-oxo-1-pyrrolidine derivatives for the preparation of a drug
12/02/2004	US20040242670 Dissolving mixture of crystalline and amorphous Atorvastatin calcium in a hydroxylic solvent, drying resulting solution to remove solvent,and isolating amorphous Atorvastatin calcium in pure form
12/02/2004	US20040242656 N-heterocyclicamide compounds; useful in the treatment of cardiovascular disorders, in particular, as an anticoagulant
12/02/2004	US20040242636 Enzyme inhibitors as antiinflammatory ageents for psoriasis, obesity
12/02/2004	US20040242633 Compound used to lower cholesterol, reduce weight for dietetics, antidepressants and antidiabetic agents
12/02/2004	US20040242631 PI-3 kinase inhibitor prodrugs
12/02/2004	US20040242627 2-Iminoimidazole derivatives (1)
12/02/2004	US20040242584 Muscarinic agonists
12/02/2004	US20040242574 Anticancer agents; antiarthritic agents
12/02/2004	US20040242572 New carboxamide compounds having melanin concentrating hormone antagonistic activity, pharmaceutical preparations comprising these compounds and process for their manufacture
12/02/2004	US20040242539 Method of enhancing lysosomal alpha-galactosidase A
12/02/2004	US20040242492 Mandelic acid derivatives and their use as thrombin inhibitors

1 ... 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 ... 404